C
IRadimed Corporation IRMD
$52.21 $0.771.50%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 13.37% -0.35% 17.26% 21.44% 23.58%
Total Depreciation and Amortization -5.11% 4.05% 6.24% 23.82% 129.64%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -15.84% 41.96% -79.56% 75.84% -34.41%
Change in Net Operating Assets 115.74% 171.23% 791.83% -1,240.41% -85.34%
Cash from Operations 53.02% 554.53% 88.93% -16.42% 28.75%
Capital Expenditure -424.57% -1,136.61% -454.40% 95.77% -106.08%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -164.22% -53.93% 21.99% -29.24% 52.74%
Cash from Investing -383.04% -813.78% -235.66% 92.70% -34.15%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -84.47% -- -54.79% -- --
Repurchase of Common Stock -25.58% 43.31% 34.19% -28.06% -117.63%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- 39.68% --
Other Financing Activities -- -- -- -- --
Cash from Financing -820.60% -6,009.24% -2,082.96% 39.43% -32.29%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -83.00% 245.43% 11.91% 69.47% 27.37%
Weiss Ratings